Microfluidics-based drug-screening systems have enabled efficient and high-throughput drug screening, but their routine uses in ordinary labs are limited due to the complexity involved in device fabrication and system setup. In this work, we report an easy-to-use and low-cost arbitrarily accessible 3D microfluidic device that can be easily adopted by various labs to perform combinatorial assays for high-throughput drug screening. The device is capable of precisely performing automatic and simultaneous reagent loading and aliquoting tasks and performing multistep assays with arbitrary sequences. The device is not intended to compete with other microfluidic technologies regarding ultra-low reaction volume. Instead, its freedom from tubing or ...
Screening is a fundamental process in today’s medicine and clinical diagnostics, comprising of sever...
A wealth of small molecule compounds exist that may inhibit cancer or virus-causing diseases, and a ...
The screening and isolation of target microorganisms from mutated recombinant libraries are crucial ...
Microfluidics-based drug-screening systems have enabled efficient and high-throughput drug screening...
[[abstract]]Combinational drug treatment has the potential of improving treatment efficacy, reducing...
In this review, we give an overview of the current state of microfluidic-based high-throughput drug ...
[[abstract]]In vitro testing of drug compounds on cell models during the drug development process re...
Microfluidic devices present unique advantages for the development of efficient drug carrier particl...
Screening is a fundamental process in today’s medicine and clinical diagnostics, comprising of sever...
Herein, we describe the development of a multilayer droplet microfluidic system for creating concent...
In the last decades, the basic techniques of microfluidics for the study of cells such as cell cultu...
Enzymes are extremely valuable tools for industrial, environmental, and biotechnological application...
Drug discovery is an expensive and lengthy process. Among the different phases, drug discovery and p...
Molecular diagnostics that involve nucleic acid amplification tests (NAATs) are crucial for preventi...
Analysis of biomarkers, biomolecular indicators of medical conditions, is fundamental to the diagnos...
Screening is a fundamental process in today’s medicine and clinical diagnostics, comprising of sever...
A wealth of small molecule compounds exist that may inhibit cancer or virus-causing diseases, and a ...
The screening and isolation of target microorganisms from mutated recombinant libraries are crucial ...
Microfluidics-based drug-screening systems have enabled efficient and high-throughput drug screening...
[[abstract]]Combinational drug treatment has the potential of improving treatment efficacy, reducing...
In this review, we give an overview of the current state of microfluidic-based high-throughput drug ...
[[abstract]]In vitro testing of drug compounds on cell models during the drug development process re...
Microfluidic devices present unique advantages for the development of efficient drug carrier particl...
Screening is a fundamental process in today’s medicine and clinical diagnostics, comprising of sever...
Herein, we describe the development of a multilayer droplet microfluidic system for creating concent...
In the last decades, the basic techniques of microfluidics for the study of cells such as cell cultu...
Enzymes are extremely valuable tools for industrial, environmental, and biotechnological application...
Drug discovery is an expensive and lengthy process. Among the different phases, drug discovery and p...
Molecular diagnostics that involve nucleic acid amplification tests (NAATs) are crucial for preventi...
Analysis of biomarkers, biomolecular indicators of medical conditions, is fundamental to the diagnos...
Screening is a fundamental process in today’s medicine and clinical diagnostics, comprising of sever...
A wealth of small molecule compounds exist that may inhibit cancer or virus-causing diseases, and a ...
The screening and isolation of target microorganisms from mutated recombinant libraries are crucial ...